Skip to main content

Table 1 Comparison of features of TICORA, BeSt, and Corrona T2T with EULAR recommendations[12]

From: The rheumatoid arthritis treat-to-target trial: a cluster randomized trial within the Corrona rheumatology network

  TICORA BeSt Corrona T2T EULAR
Mandated acceleration Yes Yes Yes Yes
Biologics accessible No Yes Yes Yes
Predefined acceleration order of therapeutic options Yes Yes No No
Biologic prevalence in RA population ≥20% No No Yes No
Unique cost-effectiveness climate Yes Yes Yes Yes
  1. BeSt: Behandel Strategieen (study); EULAR, European League Against Rheumatism; RA, rheumatoid arthritis; T2T, treat to target; TICORA: Tight Control of Rheumatoid Arthritis.